Exhibit 99.1
Company Contact: | Investor Relations Contact: |
PHC, Inc. | Liolios Group, Inc. |
Bruce A. Shear | Scott Kitcher or Ron Both |
President & CEO | info@liolios.com |
Tel: 978-536-2777 | Tel: 949-574-3860 |
PHC Reports Fourth Quarter and Fiscal Year 2008 Results
PHC Sets New Annual Revenue Record of $50.3 Million
Peabody, Mass. – September 25, 2008 – PHC, Inc., d.b.a. Pioneer Behavioral Health (AMEX:PHC), a leading provider of inpatient and outpatient behavioral health services, reported financial results for the company’s fourth quarter and fiscal year ended June 30, 2008.
Fourth Quarter Fiscal 2008 Financial and Operating Highlights
• | Q4 2008 revenues of $12.8 million unchanged from same year-ago quarter, and increased 5% sequentially. |
• | Patient care revenue increased 2% vs. Q4 2007. |
• | Contract support revenue decreased 1% vs. Q4 2007. |
• | Patient days increased 6.2% vs. Q4 2007. |
• | Started admitting patients to the newly opened Seven Hills Behavioral Institute in Henderson, Nevada, which is expected to generate approximately $12 million annually, along with higher margins than PHC's other inpatient facilities. |
• | Secured building site for two new behavioral treatment facilities as part of new major expansion in Las Vegas, with one planned to have the capacity to generate more than $25 million annually. |
Fiscal Year 2008 Financial and Operating Highlights
• | Fiscal 2008 record revenues of $50.3 million increased $5.2 million or 12% over fiscal 2007, attributable to improvement in core patient care business |
• | Patient care revenue rose 13% over previous year to a record $40.9 million |
• | Contract support revenue increased slightly over FY2007 |
• | Patient days increased 6.5% vs. FY2007 |
Key Financial Indicators
(Dollars in thousands except per-share amounts.)
| Q4 FY2008 | Q4 FY2007 |
| FY2008 | FY2007 |
|
| ||||
Total revenues | $12,779 | $12,795 |
| $50,320 | $45,127 |
Patient care revenues | 10,372 | 10,177 |
| 40,856 | 36,023 |
Income before Pivotal impairment loss: | 342 | 1,421 |
| 2,691 | 2,829 |
Net income* (loss) | (1,021) | 822 |
| 417 | 1,682 |
Earnings (loss) per share – Basic* | (0.05) | 0.04 |
| 0.02 | 0.09 |
Earnings (loss) per share – Diluted* | (0.05) | 0.04 |
| 0.02 | 0.09 |
*Includes start-up losses from new Hospital of $652,000 for Q4 FY2008 and $765,000 for the full year FY2008.
Management Commentary
“The five percent improvement in net revenues over the previous quarter helped bring in another record breaking year in annual revenue,” said Bruce A. Shear, Pioneer's president and CEO, “and we achieved yet another profitable quarter despite incurring more than $652,000 in startup losses of our new Seven Hills Behavioral Institute.”
“While we have been enjoying solid growth in patient care, we are also seeing an increase in utilization of our capitated contracts, continued Shear, “This has triggered the process of renegotiating these agreements for future periods, with the potential for increased revenue and improved margins for this segment of our business."
“Now with the Seven Hills facility approaching breakeven, the divesture of Pivotal we announced yesterday, and no major construction or startups planned for the next two years, we have better clarity into the growth of our business in 2009. We expect our patient care revenue to grow more than 20% in fiscal 2009, along with an achievable goal of income before taxes of 8-10% of net revenue as we approach fiscal 2010. The visible improvement will come during the second half of 2009, as our newest projects, particularly our Capstone Academy in Detroit, come up to speed."
Fourth Quarter 2008 Financial Results
For the fourth quarter ended June 30, 2008, total net revenue from operations totaled $12.8 million, which was virtually unchanged from the fourth quarter of fiscal 2007. Patient care segment revenue increased 2% to $10.4 million from the same year ago quarter, while contract support services revenue from the company’s Wellplace subsidiary decreased 1% to $1.1 million.
Pioneer announced yesterday a plan to divest the operations of its Pivotal Research Centers, which comprise the pharmaceutical studies segment, and focus on its core business that delivers behavioral health programs and services. The company signed a letter of intent for the purchase of Pivotal by a major research organization for approximately $4.5 million net cash to Pioneer. The Company took a write down of $1,771,000 to reflect the decreased value of the intangible assets of Pivotal, which closely reflects the potential selling price of Pivotal. In the fourth quarter, the pharmaceutical studies segment revenues declined 13% to $1.3 million.
Income from operations, excluding the Pivotal impairment loss, for the fourth quarter totaled $380,000, a decline of 69% from the same period a year ago. Income before taxes, and the impairment loss decreased 76% to $342,000 from the same year-ago period. This decrease is primarily attributable to a $183,000 or 124% decrease in income from operations by the company’s pharmaceutical studies business segment.
Net income for the quarter, excluding the Pivotal impairment loss, was $206,000 or $0.01 per fully diluted share (based on 20.5 million fully diluted shares), which declined 75% from net income of $822,000 or $0.04 per fully diluted share (based on 20.5 million shares) for the fourth quarter of fiscal 2007. This represented the company’s 25th consecutive profitable quarter, before the impairment loss, which was sustained while incurring substantial startup losses from the company’s new Seven Hills facility that started admitting patients in May of this year.
The company continued to reduce long-term debt and revolving credit note balances, decreasing these amounts from the previous quarter by $291,000 to total $2.6 million at June 30, 2008.
Full Fiscal Year 2008 Financial Results *
For the full fiscal year 2008 ended June 30, 2008, total net revenue from operations increased 12% over the previous year to a record $50.3 million. This six consecutive record annual revenue is primarily attributable to the company’s patient care segment that achieved an increase of revenue of 13% over the previous year to a record $40.9 million.
Income from operations, before the impairment loss, for the fiscal year was $2.9 million, a decline of 4% from fiscal 2007. Income before taxes and impairment loss decreased 5% to $2.7 million as compared to fiscal 2007. This decrease is primarily the result of start up losses for Seven Hills Behavioral Institute of approximately $765,000 and an increase in the number of inpatient bed days under the company’s capitated contracts.
Net income prior to the impairment loss of Pivotal for the 2008 fiscal year was $1.6 million, or $0.08 per fully diluted share (based on 20.5 million fully diluted shares), a decrease of 11% compared to net income of $1.7 million, or $0.09 per fully diluted share (based on 19.7 million shares) in fiscal 2007.
The company reduced long-term debt and revolving credit note balances from the previous fiscal year by $881,900, to total $2.6 million at June 30, 2008. Cash and cash equivalents totaled $3.3 million at June 30, 2008, as compared to $3.4 million at the end of the previous fiscal year.
Teleconference Information
PHC will host a conference call today at 4:30 p.m. Eastern Time. A question and answer session will follow management’s presentation. To participate in the call, dial the appropriate number 5-10 minutes prior to the start time, request the PHC conference call and provide the conference ID.
Domestic callers: 1-800-862-9098
International callers: 1-785-424-1051
Conference ID#: 7PHC
A web simulcast of the call can be accessed via PHC’s website at www.phc-inc.com. The call will be available for replay starting at 7:30 p.m. Eastern Time until October 25, 2008:
Toll-Free Replay number: 1-800-753-6120
International Replay number: 1-402-220-0684
(No pass code required)
If you have any difficulty connecting with the conference call or webcast, please contact the Liolios Group at 949-574-3860.
About PHC, Inc.
PHC, Inc., d/b/a Pioneer Behavioral Health, is a national healthcare company providing behavioral health services in four states, including substance abuse treatment facilities in Utah and Virginia, and inpatient and outpatient psychiatric facilities in Michigan and Nevada. The company also offers internet and telephonic-based referral services that includes EAP and critical incident services. Contracted services with government agencies, national insurance companies, and major transportation and gaming companies cover more than one million individuals. Pioneer helps people gain and maintain physical, spiritual and emotional health through delivering the highest quality, most culturally responsive and compassionate behavioral health care programs and services. For more information, visit www.phc-inc.com.
Statement under the Private Securities Litigation Reform Act of 1995
This press release may include "forward-looking statements" that are subject to risks and uncertainties. Forward-looking statements include information about possible or assumed future results of the operations or the performance of the Company and its future plans and objectives. Various future events or factors may cause the actual results to vary materially from those expressed in any forward-looking statements made in this press release. For a discussion of these factors and risks, see the company's annual report on Form 10-K for the most recently ended fiscal year.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
|
| Three Months Ended |
| For the Years Ended | ||||
|
| June 30, |
| June 30, | ||||
|
| 2008 |
| 2007 |
| 2008 |
| 2007 |
Revenues: |
|
|
|
|
|
|
|
|
Patient care, net | $ | 10,372,134 | $ | 10,176,816 | $ | 40,856,077 | $ | 36,022,529 |
Pharmaceutical studies |
| 1,276,431 |
| 1,474,816 |
| 4,922,790 |
| 4,564,314 |
|
|
|
|
|
| |||
Contract support services |
| 1,130,037 |
| 1,143,236 |
| 4,541,260 |
| 4,540,634 |
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
Total revenues |
| 12,778,602 |
| 12,794,868 |
| 50,320,127 |
| 45,127,477 |
|
|
|
|
| ||||
Operating expenses: |
|
|
|
|
|
|
|
|
Patient care expenses |
| 5,688,721 |
| 5,443,225 |
| 22,133,200 |
| 19,738,357 |
Patient care expenses, pharmaceutical |
| 619,841 |
| 672,134 |
| 2,752,520 |
| 2,182,357 |
Cost of contract support services |
| 869,139 |
| 799,929 |
| 3,390,224 |
| 3,102,551 |
Provision for doubtful accounts |
| 342,660 |
| 706,704 |
| 1,311,431 |
| 1,933,499 |
Administrative expenses |
| 4,207,079 |
| 3,328,041 |
| 15,464,544 |
| 12,722,007 |
Administrative expenses, pharmaceutical |
|
671,705 |
|
632,054 |
|
2,377,082 |
|
2,438,802 |
Impairment loss, Pivotal |
| 1,771,000 |
| ________- |
| 1,771,000 |
| ________-- |
Total operating expenses |
| 14,170,145 |
| 11,582,087 |
| 49,200,001 |
| 42,117,573 |
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
Income (loss) from operations |
| (1,391,543) |
| 1,212,781 |
| 1,120,126 |
| 3,009,904 |
|
|
|
|
| ||||
Other income (expense): |
|
|
|
|
|
|
|
|
Interest income |
| 46,682 |
| 40,514 |
| 194,310 |
| 159,946 |
Other income/expense |
| 13,527 |
| 316,107 |
| 54,729 |
| 308,599 |
Interest expense |
| (97,419) |
| (148,098) |
| (448,852) |
| (649,166) |
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
Total other expenses, net |
| (37,210) |
| 208,523 |
| (199,813) |
| (180,621) |
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
| (1,428,753) |
| 1,421,304 | $ | 920,313 | $ | 2,829,283 |
Benefit from (provision for) income taxes |
|
408,187 |
|
(599,171) |
|
(503,001) |
|
(1,147,000) |
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
Net income (loss) | $ | (1,020,566) | $ | 822,133 | $ | 417,312 | $ | 1,682,283 |
|
|
|
|
| ||||
Basic net income (loss) per common share |
$ |
( 0.05) |
|
0.04 |
|
0.02 |
|
0.09 |
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
Basic weighted average number of shares outstanding |
|
20,198,572 |
|
20,039,987 |
|
20,166,659 |
|
19,287,665 |
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
Fully diluted net income (loss) per common share |
$ |
( 0.05) |
$ |
0.04 |
$ |
0.02 |
$ |
0.09 |
|
|
|
|
|
| |||
Fully diluted weighted average number of shares outstanding |
|
20,489,842 |
|
20,542,040 |
|
20,464,255 |
|
19,704,697 |
RECONCILIATION OF NON-GAAP INCOME STATEMENTS
(Unaudited)
|
| Three Months Ended |
| For the Years Ended | ||||
|
| June 30, |
| June 30, | ||||
|
| 2008 |
| 2007 |
| 2008 |
| 2007 |
Revenues: |
|
|
|
|
|
|
|
|
Patient care, net | $ | 10,372,134 | $ | 10,176,816 | $ | 40,856,077 | $ | $36,022,529 |
Pharmaceutical studies |
| 1,276,431 |
| 1,474,816 |
| 4,922,790 |
| 4,564,314 |
Contract support services |
| 1,130,037 |
| 1,143,236 |
| 4,541,260 |
| 4,540,634 |
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
Total revenues |
| 12,778,602 |
| 12,794,868 |
| 50,320,127 |
| 45,127,477 |
|
|
|
|
| ||||
Operating expenses: |
|
|
|
|
|
|
|
|
Patient care expenses |
| 5,688,721 |
| 5,443,225 |
| 22,133,200 |
| 19,738,357 |
Patient care expenses, pharmaceutical |
| 619,841 |
| 672,134 |
| 2,752,520 |
| 2,182,357 |
Cost of contract support services |
| 869,139 |
| 799,929 |
| 3,390,224 |
| 3,102,551 |
Provision for doubtful accounts |
| 342,660 |
| 706,704 |
| 1,311,431 |
| 1,933,499 |
Administrative expenses |
| 4,207,079 |
| 3,328,041 |
| 15,464,544 |
| 12,722,007 |
Administrative expenses, pharmaceutical |
|
671,705 |
|
632,054 |
|
2,377,082 |
|
2,438,802 |
Impairment loss, Pivotal |
| 1,771,000 |
| ________- |
| 1,771,000 |
| ________-- |
|
|
|
|
| ||||
Total operating expenses |
| 14,170,145 |
| 11,582,087 |
| 49,200,001 |
| 42,117,573 |
|
|
|
|
| ||||
Income (loss) from operations |
| (1,391,543) |
| 1,212,781 |
| 1,120,126 |
| 3,009,904 |
|
|
|
|
| ||||
Impairment loss, Pivotal |
| 1,771,000 |
| -- |
| 1,771,000 |
| -- |
|
|
|
|
| ||||
Non-GAAP Income before Pivotal Impairment loss |
|
379,457 |
|
1,212,781 |
|
2,891,126 |
|
3,009,904 |
|
|
|
|
|
|
|
|
|
Other income (expense): |
|
|
|
|
|
|
|
|
Interest income |
| 46,682 |
| 40,514 |
| 194,310 |
| 159,946 |
Other income/expense |
| 13,527 |
| 316,107 |
| 54,729 |
| 308,599 |
Interest expense |
| (97,419) |
| (148,098) |
| (448,852) |
| (649,166) |
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
Total other expenses, net |
| (37,210) |
| 208,523 |
| (199,813) |
| (180,621) |
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
Non-GAAP Income (loss) before income taxes and impairment loss |
$ |
$342,247 |
$ |
1,421,304 |
$ |
2,691,313 |
$ |
2,829,283 |